EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.37B
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
489
New
Increased
Reduced
Closed

Top Buys

1 +$483M
2 +$247M
3 +$186M
4
TSM icon
TSMC
TSM
+$179M
5
MSFT icon
Microsoft
MSFT
+$143M

Top Sells

No sells this quarter

Sector Composition

1 Technology 52.03%
2 Consumer Discretionary 19.21%
3 Communication Services 9.64%
4 Healthcare 4.63%
5 Consumer Staples 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTD icon
326
Mettler-Toledo International
MTD
$27.1B
$414K 0.01%
+328
MO icon
327
Altria Group
MO
$107B
$413K 0.01%
+6,258
TRMB icon
328
Trimble
TRMB
$16.1B
$413K 0.01%
+6,328
IQV icon
329
IQVIA
IQV
$29.6B
$409K 0.01%
+2,396
TYL icon
330
Tyler Technologies
TYL
$14.5B
$406K 0.01%
+1,186
IAG icon
331
IAMGOLD
IAG
$11.2B
$405K 0.01%
+21,516
CBOE icon
332
Cboe Global Markets
CBOE
$31.4B
$404K 0.01%
+1,436
EQX icon
333
Equinox Gold
EQX
$12.3B
$399K 0.01%
+27,608
SO icon
334
Southern Company
SO
$107B
$394K 0.01%
+4,079
WST icon
335
West Pharmaceutical
WST
$19.7B
$390K 0.01%
+1,556
STE icon
336
Steris
STE
$22.1B
$390K 0.01%
+1,763
HUM icon
337
Humana
HUM
$24.6B
$388K 0.01%
+2,235
DGX icon
338
Quest Diagnostics
DGX
$21.6B
$384K 0.01%
+1,958
LH icon
339
Labcorp
LH
$22.2B
$383K 0.01%
+1,437
AG icon
340
First Majestic Silver
AG
$10.6B
$382K 0.01%
+17,806
CME icon
341
CME Group
CME
$104B
$380K 0.01%
+1,288
CPRX icon
342
Catalyst Pharmaceutical
CPRX
$3.21B
$376K 0.01%
+15,177
VTRS icon
343
Viatris
VTRS
$17.1B
$372K 0.01%
+27,545
HOLX
344
DELISTED
Hologic
HOLX
$370K 0.01%
+4,898
TEAM icon
345
Atlassian
TEAM
$17.7B
$367K 0.01%
+5,378
SNDX icon
346
Syndax Pharmaceuticals
SNDX
$2.14B
$366K 0.01%
+15,678
ZBH icon
347
Zimmer Biomet
ZBH
$18.3B
$366K 0.01%
+4,049
DNLI icon
348
Denali Therapeutics
DNLI
$3.26B
$364K 0.01%
+18,942
MPC icon
349
Marathon Petroleum
MPC
$62.9B
$364K 0.01%
+1,489
IDYA icon
350
IDEAYA Biosciences
IDYA
$2.98B
$363K 0.01%
+10,897